Stay updated on Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Sign up to get notified when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.3 to v3.6.4, reflecting a new build of the page. No study content or functionality is affected.
    Difference
    0.1%
    Check dated 2026-07-26T19:03:49.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The history now includes a new entry for Revision: v3.6.3 and removes the previous v3.6.2 entry, reflecting an updated software release in the page's history.
    Difference
    0.1%
    Check dated 2026-07-05T04:30:19.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page footer revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the study record history page; this is a metadata update with no changes to the displayed study data.
    Difference
    0.1%
    Check dated 2026-06-27T23:27:13.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', indicating enrollment is closed. The history now shows Revision: v3.6.0 and removes the prior Revision: v3.5.5 entry.
    Difference
    0.2%
    Check dated 2026-06-13T17:56:22.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the study record history, representing an updated version of the record. The previous revision v3.5.4 remains part of the history as the prior version.
    Difference
    0.1%
    Check dated 2026-06-06T14:46:10.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the study record history, replacing the prior v3.5.3. This reflects an updated version of the record in the history.
    Difference
    0.1%
    Check dated 2026-05-16T09:19:33.000Z thumbnail image

Stay in the know with updates to Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.